ºÚÁÏÍø

ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 4334

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

GAPDH mRNA expression in blood of Moroccan AD cases

9th International Conference on Alzheimers Disease & Dementia

Nadia El Kadmiri, Meryam El Khachibi, Ilham Slassi, Bouchra El Moutawakil , Sellama Nadifi and Abdelaziz Soukri

IBN ZOHR University, Morocco Hassan II University of Casablanca, Morocco Hassan II University of Casablanca, Morocco

ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism

DOI:

Abstract
Introduction: Proteomics studies have been conducted to identify proteins affecting the degree of neurodegeneration and could contribute to discover and define predictive biomarker signatures for AD. Several studies have highlighted the high affinity interactions between GAPDH - �²-amyloid in Alzheimer disease. The aim of our study to assess the mRNA expression of GAPDH in the blood of Moroccan AD cases. Methods: A quantitative Real Time PCR was performed to evaluate the mRNA expression of GAPDH in samples of AD cases and healthy controls. Results: the mRNA expression level of GAPDH in AD cases was significantly different as compared to healthy controls (P< 0.05). Conclusion: Our results reveal that GAPDH undergoes several modifications in neurodegeneration mechanism, that affect its chemical structure and its biological activity, which could contribute as a biomarker for AD.
Biography
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top